Short pages

Jump to navigation Jump to search

Showing below up to 50 results in range #11,721 to #11,770.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. (hist) Hepatic encephalopathy screening [297 bytes]
  2. (hist) Acute retinal necrosis future or investigational therapies [297 bytes]
  3. (hist) Protein energy malnutrition CT [297 bytes]
  4. (hist) Barrett's esophagus MRI [297 bytes]
  5. (hist) Papillary thyroid cancer secondary prevention [297 bytes]
  6. (hist) Paroxysmal AV block Diagnostic Summary table [297 bytes]
  7. (hist) Social Media Project [297 bytes]
  8. (hist) Afib comorbidities RF management [297 bytes]
  9. (hist) Somatic sensory cortex [298 bytes]
  10. (hist) Gene dosage [298 bytes]
  11. (hist) Feminine wipe [298 bytes]
  12. (hist) Pill dispenser [298 bytes]
  13. (hist) Lapdap [298 bytes]
  14. (hist) Michael Lesch [298 bytes]
  15. (hist) Cicatrizant [298 bytes]
  16. (hist) Lappa [298 bytes]
  17. (hist) Myriogramme [298 bytes]
  18. (hist) Andrew Thompson (parasitologist) [298 bytes]
  19. (hist) Couvelaire uterus [298 bytes]
  20. (hist) Mortal Wound [298 bytes]
  21. (hist) Clot retraction [298 bytes]
  22. (hist) Trousseau sign [298 bytes]
  23. (hist) Cefuroxime contraindications [298 bytes]
  24. (hist) Pratt's sign [298 bytes]
  25. (hist) Hypertrophic cardiomyopathy epidemiology and genetics [298 bytes]
  26. (hist) Right heart failure CT [298 bytes]
  27. (hist) Xanthomatous biliary cirrhosis [298 bytes]
  28. (hist) Obesity MRI [298 bytes]
  29. (hist) Splenomegaly classification [298 bytes]
  30. (hist) Acute pancreatitis screening [298 bytes]
  31. (hist) Abdominal angina MRI [298 bytes]
  32. (hist) Cholestasis ultrasound [298 bytes]
  33. (hist) Mast cell sarcoma case study one [298 bytes]
  34. (hist) Gestational diabetes future or investigational therapies [298 bytes]
  35. (hist) Diabetic ketoacidosis future or investigational therapies [298 bytes]
  36. (hist) Autoimmune lymphoproliferative syndrome case study one [298 bytes]
  37. (hist) Autoimmune lymphoproliferative syndrome cost-effectiveness of therapy [298 bytes]
  38. (hist) Autoimmune lymphoproliferative syndrome future or investigational therapies [298 bytes]
  39. (hist) Spherocytosis epidemiology and demographics [298 bytes]
  40. (hist) Dyspnea risk factors [298 bytes]
  41. (hist) Dyspnea echocardiography [298 bytes]
  42. (hist) Hemosiderosis primary prevention [298 bytes]
  43. (hist) Mesangial proliferative glomerulonephritis historical perspective [298 bytes]
  44. (hist) Mesangial proliferative glomerulonephritis classification [298 bytes]
  45. (hist) Mesangial proliferative glomerulonephritis causes [298 bytes]
  46. (hist) Mesangial proliferative glomerulonephritis differential diagnosis [298 bytes]
  47. (hist) Mesangial proliferative glomerulonephritis epidemiology and demographics [298 bytes]
  48. (hist) Mesangial proliferative glomerulonephritis risk factors [298 bytes]
  49. (hist) Mesangial proliferative glomerulonephritis screening [298 bytes]
  50. (hist) Mesangial proliferative glomerulonephritis natural history, complications and prognosis [298 bytes]

View ( | ) (20 | 50 | 100 | 250 | 500)